Skip to main content

Robert A. Ingram
Member of the Board

Member of the Board of Directors since 2006, Member of the Compensation and of the Nominating Committees, US national

BSc in business administration; since 2007 General Partner at Hatteras Venture Partners. Prior to this, various executive positions at Glaxo Wellcome and GlaxoSmithKline (1990 to 2010)

Chairman of the Board of Directors Selenity (formerly Viamet Pharmaceuticals Inc.) since 2015, Novan Inc. since 2011 and BioCryst Pharmaceuticals Inc. since 2015